COMMUNIQUÉS West-GlobeNewswire

Oxford Biomedica plc: Preliminary results for the year ended 31 December 2018
14/03/2019
Oxford Biomedica plc Preliminary results for the year ended 31 December 2018 Delivery of dual strategy leads to strong financial growth Oxford, UK – 14 March 2019 : Oxford Biomedica plc (LSE: OXB), (“OXB” or “the Group [...]
Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan
14/03/2019
EAST RUTHERFORD, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
VBL Therapeutics to Report Fiscal Year 2018 Financial Results on March 28
14/03/2019
TEL AVIV, Israel, March 14, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Spring Bank Pharmaceuticals to Participate in Jefferies 2019 HBV Summit
14/03/2019
HOPKINTON, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
BioCorRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019
14/03/2019
ANAHEIM, CA, March 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (“Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, announced today [...]
Integra LifeSciences Announces the Approval of DuraGen® in Japan
14/03/2019
PLAINSBORO, N.J. and TOKYO, March 14, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART ), a global leader in medical technology, announces the recent approval of DuraGen ® Dural [...]
Stryker acquires OrthoSpace, Ltd.
14/03/2019
Kalamazoo, Michigan, March 14, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today it has completed the acquisition of OrthoSpace, Ltd., a privately held company founded in 2009 and headquartered in Caesarea, [...]
Eton Pharmaceuticals Submits New Drug Application for DS-200
14/03/2019
FDA Previously Granted DS-200 Fast Track Designation DEER PARK, Ill., March 14, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), today announced that the Company has submitted a New Drug Application ( [...]
electroCore Announces Encouraging Research Supporting Key Areas of Clinical Development for its Non-Invasive Vagus Nerve Stimulator, gammaCore™
14/03/2019
Data presented at the 3rd International Brain Stimulation Conference support the use of nVNS for treatment of mild traumatic brain injury and rheumatoid arthritis BASKING RIDGE, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- [...]
iCAD to Present Corporate Overview at the 31st Annual ROTH Conference
14/03/2019
NASHUA, N.H., March 14, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief [...]
Gala Pharmaceutical Starts Construction of Its Long Beach California Testing Facility
14/03/2019
IRVINE, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- IRVINE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. ( GLPH ), a provider of cannabis testing in Southern California, today announced that it [...]
Cue Biopharma to Present Corporate Overview and Update at the Oppenheimer 29th Annual Healthcare Conference
14/03/2019
CAMBRIDGE, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the [...]
Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2018 Financial Results and Business Update
14/03/2019
AZEDRA ® (iobenguane I 131) U.S. Commercial Launch – 14 Treatment Requests from Patients Have Been Received and Scheduling for those Patients is Underway; 8 Centers Throughout the U.S. are Ready to Treat Patients [...]
Progenics Asserts Ownership of PSMA-617 Intellectual Property, Including Composition of Matter Patent
14/03/2019
NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company focused on the development and commercialization of innovative targeted medicines and artificial [...]
Radient Technologies Inc. Announces Commencement of Production of Cannabis Extracts at Commercial Scale
14/03/2019
EDMONTON, Alberta, March 14, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that it has begun production of cannabis extracts at [...]
Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
14/03/2019
Phase 1 trial confirmed superior bioavailability of intranasal betahistine as well as good safety and tolerability Intranasal betahistine program progressing towards proof-of-concept studies in acute vertigo (AM-125) [...]
Emerald Health Therapeutics Continues to Grow Sales with First Cannabis Shipment to Ontario Cannabis Retail Corporation
14/03/2019
Ontario marks a key province to offer Emerald-branded cannabis products, expanding Emerald’s market opportunity to over half of the Canadian cannabis-consuming population VICTORIA, British Columbia, March 14, 2019 ( [...]
Kamada Awarded the Israeli Outstanding Exporter Award for 2017
14/03/2019
Company received the award from the Israeli Minister of Economy and Industry for its growing export revenues For fiscal 2017, Kamada's total revenues were $102.8 Million, an increase of more than 33% compared to 2016. [...]
Summit Highlights Use of Discuva Platform in Identifying New Mechanism Antibiotics against Neisseria Gonorrhoeae and ESKAPE Pathogens at Novel Antimicrobials and AMR Diagnostics 2019 Conference
14/03/2019
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Highlights Use of Discuva Platform in Identifying New Mechanism Antibiotics against Neisseria Gonorrhoeae and ESKAPE Pathogens at Novel Antimicrobials and AMR [...]

Pages